Protein Expression Global Market Sees Growth Rate Of 11% Through 2022
11 Feb, 2022
The global protein expression market size is expected to grow from $2.58 billion in 2021 to $2.87 billion in 2022 at a compound annual growth rate (CAGR) of 11.4%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The protein expression market is expected to reach $4.39 billion in 2026 at a CAGR of 11.2%.
What is the Global Protein Expression Market?
The protein expression market consists of sales of protein expression vectors, competent cells, reagents, equipment and related services. Protein expression is a process in which proteins are synthesized, modified, regulated and controlled in living organisms according to the host cell. Protein expression included yeast expression, insect expression, and bacterial expression, algal expression and mammalian cell expression.
Get a Sample of the global protein expression market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2493&&type=smp
What drives the Global Protein Expression Market?
Increase in demand for biologics to counter various genetic disorders and chronic diseases is one the major factors driving the research and sales of protein expression market. Biologics is a medicine produced from living organisms or contains components of living organisms such as protein, tissue, genes, allergens, cells, blood components, blood, and vaccines. The increasing use of biologics (therapeutic protein and others) to cure chronic diseases such as cancer, cardiovascular conditions and genetic disorders, is increasing the demand for protein expression devices and equipment. According to the World Health Organization, chronic disease prevalence rose by 57% globally, in the year 2020. Hence the rising demand for biologics is driving the protein expression market. For instance, according to an article published by Chemistry World, analysts stated that the biologics market hold a market share of more than a quarter of the entire pharmaceutical market in 2020. The global biologics market is expected to grow at 14.7% during 2021-2023.
Get the full global protein expression industry report here:
https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-reportGlobal Protein Expression Market Segments
The global protein expression market is segmented:
By Protein Expression: Yeast Expression, Mammalian Expression, Algae Expression, Insect Expression, Bacterial Expression, Cell-free Expression
By End Use: Pharmaceutical and Biotechnological Companies, Academic Research, Contract Research Organizations
By Product: Reagents, Competent Cells, Expression Vectors, Services, Instruments
By Application: Therapeutic, Industrial, Research
By Geography: The regions covered in the protein expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Protein Expression Global Market Report 2022provides market size and growth forecasts for the global protein expression market, global protein expression market share, protein expression market segments and geographies, protein expression market competitive landscape including leading competitors’ revenues, profiles and market shares. The protein expression market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Protein Expression Industry Playersinclude Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc, New England Biolabs, Promega Corporation, Qiagen, Takara Bio, Merck KGaA, Genscript Biotech Corporation, Life Technologies Corporation, Sigma-Aldrich Corporation, Lucigen Corporation, Synthetic Genomics Inc., Becton, Dickinson & Company, Lonza Group Ltd, Accelagen Inc., Geneva Biotech, Viva Biotech, Becton, Dickinson & Company, Sengenics, ARTES Biotechnology GmbH, Addgene Inc, Profacgen, ProteoGenix, Peak Proteins Ltd, Domainex Ltd, Jena Bioscience GmbH, EMD Millipore, and Oxford Expression Technologies Ltd. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.